Regulating Advanced Therapies
Published Friday, November 17, 2017 | POSTnotes POST-PN-0567
A POSTnote which explains what advanced therapies are and how they can benefit patients, and gives an overview of the current regulatory framework and how this might change after Brexit.
New Plant Breeding Techniques
Published Wednesday, February 1, 2017 | POSTnotes POST-PN-0548
This note outlines some of the new plant breeding techniques developed recently and looks at their applications and the regulatory challenges they raise
Implications of the Accelerated Access Review for cystic fibrosis and other conditions
Published Monday, December 12, 2016 | Commons Debate packs CDP-2016-0242
This Debate Pack has been prepared ahead of the debate on the Implications of the Accelerated Access Review for cystic fibrosis and other conditions, to be held in Westminster Hall on Tuesday 13 December at 9.30am.
The subject for the debate has been chosen by the Backbench Business Committee, following a representation made by Ian Austin, Ben Howlett and Kerry McCarthy.
Sources of Statistics: Health
Published Wednesday, July 13, 2016 | Commons Briefing papers SN03843
This introductory guide provides sources of statistics on UK public health services.
Animal Experiment Statistics
Published Monday, January 18, 2016 | Commons Briefing papers SN02720
In 2014 3.8 million procedures were completed on regulated living animals representing a decrease of 6% compared to 2013. This note summarises and analyses trends in data, including the growth of universities as the dominant seat of research on animals, the decline of research for toxicological purposes, and the growth in animal procedures for cancer research.
Published Thursday, January 29, 2015 | Commons Briefing papers SN06833
This note seeks to provide a summary of the role of mitochondria, mitochondrial disease and the proposed new techniques. It will also outline the investigations into these techniques that took place prior to the Government announcement; a HFEA scientific review of the safety and efficacy of methods, an ethical review of the techniques for mitochondrial replacement undertaken by the Nuffield Council on Bioethics and an HFEA public consultation. The main safety and ethical considerations associated with the introduction of these techniques into clinical practice will be discussed.
GM Insects and Disease Control
Published Tuesday, November 4, 2014 | POSTnotes POST-PN-483
Insects play a critical role in ecosystems, but can also cause economic and social harm by transmitting diseases to humans and livestock, and damaging crops. Genetically modified (GM) insects could be used alongside other approaches to mitigate harms. This POSTnote summarises possible benefits, risks and uncertainties associated with their deployment.
GM Crops and Regulation
Published Thursday, October 30, 2014 | POSTnotes POST-PN-482
This note summarises the evidence on environmental and health impacts of GM crops, describes recent technological developments and examines their likely consequences for proposed reforms of GM regulation
Preventing Mitochondrial Disease
Published Tuesday, October 14, 2014 | POSTnotes POST-PN-431
This note describes new treatments designed to prevent mothers with mitochondrial disease passing their condition on to their children and looks at the issues raised by their potential use in IVF.
Published Wednesday, July 30, 2014 | POSTnotes POST-PN-473
A POSTnote that explores the role of biobanks in health research.
Surveillance of infectious disease
Published Wednesday, March 26, 2014 | POSTnotes POST-PN-462
This briefing describes current surveillance efforts and examines new technological developments and their likely impacts on UK and international public health.
Epigenetics and Health
Published Wednesday, December 18, 2013 | POSTnotes POST-PN-451
This POSTnote examines how recent advances in epigenetics can be used to develop new treatments, inform public health policy, and contribute to the UK economy.
Published Friday, December 21, 2012 | POSTnotes POST-PN-424
The use of genetically modified (GM) plants to produce pharmaceutical drugs and vaccines is an emerging technology that offers a low-cost, large-scale alternative to current methods. This POSTnote looks at recent advances in, and the benefits of, the technology, and analyses the associated biosafety and regulatory issues.
Consumer Genetic Testing
Published Thursday, March 15, 2012 | POSTnotes POST-PN-407
This POSTnote explores the scientific, regulatory, and ethical issues related to genetic tests sold to consumers.
Published Wednesday, October 12, 2011 | POSTnotes POST-PN-393
This note describes current technologies used in livestock breeding, research into future technologies and how the improvement of livestock can contribute towards future food security.
GM crops and food security
Published Thursday, September 15, 2011 | POSTnotes POST-PN-386
This POSTnote examines the potential contribution that genetic modification of crops might bring to increasing food production in Europe, in a global context.
Science in the New Parliament, 2010
Published Saturday, May 1, 2010 | POSTbriefs POST-Report-12
After every general election, POST produces a special briefing highlighting some of the main science-based issues that the new Parliament is likely to encounter.
Topics: Aviation, Climate change, Defence policy, Diseases, Energy, Environmental protection, Genetics, Health education and preventive medicine, Health services, Information technology, International development, Internet and cybercrime, Medical ethics, Medicine, Older people, Population, Privacy, Research and innovation, Roads, Science, Shipping, Telecommunications, Water